Lars Holmgren

9.6k total citations · 2 hit papers
77 papers, 7.6k citations indexed

About

Lars Holmgren is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Lars Holmgren has authored 77 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 29 papers in Cell Biology and 14 papers in Immunology. Recurrent topics in Lars Holmgren's work include Hippo pathway signaling and YAP/TAZ (24 papers), Angiogenesis and VEGF in Cancer (23 papers) and Cellular Mechanics and Interactions (12 papers). Lars Holmgren is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (24 papers), Angiogenesis and VEGF in Cancer (23 papers) and Cellular Mechanics and Interactions (12 papers). Lars Holmgren collaborates with scholars based in Sweden, United States and Italy. Lars Holmgren's co-authors include Michael S. O’Reilly, Judah Folkman, Judah Folkman, Catherine Chen, Anders Bratt, Anna Szeles, Rolf Ohlsson, Anna‐Lena Spetz, Anna Bergsmedh and Boris Troyanovsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Lars Holmgren

75 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1995 1.5k citations Lars Holmgren et al. profile →
Angiostatin induces and sustains dormancy of human primary tumors in mice

1996 975 citations Lars Holmgren, Catherine Chen et al. profile →

Peers

Countries citing papers authored by Lars Holmgren

Since Specialization

Citations

This map shows the geographic impact of Lars Holmgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Holmgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Holmgren more than expected).

Fields of papers citing papers by Lars Holmgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Holmgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Holmgren. The network helps show where Lars Holmgren may publish in the future.

Co-authorship network of co-authors of Lars Holmgren

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Holmgren. A scholar is included among the top collaborators of Lars Holmgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Holmgren. Lars Holmgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulation of YAP Promotor Accessibility in Endothelial Mechanotransduction 2024 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), Honglei Zhao, Yuanyuan Zhang, (unknown), Otto Bergman, Joy Roy, Pipsa Saharinen, Lars Holmgren	9
2	A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells 2024 ·Journal of Experimental & Clinical Cancer Research ·Pedro Fonseca, Weiyingqi Cui, (unknown), Le Tong, (unknown), (unknown), Honglei Zhao, (unknown), Xinsong Chen, Nicholas P. Tobin, Brinton Seashore‐Ludlow, Andreas Lundqvist, Johan Hartman, Anita Göndör, Päivi Östling, Lars Holmgren	0
3	Modulation of E-Cadherin Function through the AmotL2 Isoforms Promotes Ameboid Cell Invasion 2023 ·Cells ·(unknown), Weiyingqi Cui, Yuanyuan Zhang, Tomas Friman, (unknown), Wenmao Huang, Pedro Fonseca, Weng‐Onn Lui, (unknown), Justyna Bobrowska, Małgorzata Lekka, Jie Yan, Daniel E. Conway, Lars Holmgren	2
4	Nuclear mechanosensing of the aortic endothelium in health and disease 2023 ·Disease Models & Mechanisms ·(unknown), Lars Holmgren	5
5	Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment 2023 ·Cells ·Weiyingqi Cui, (unknown), Pedro Fonseca, Yumeng Zhang, Le Tong, Yuanyuan Zhang, Lars Egevad, Andreas Lundqvist, Lars Holmgren	1
6	p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin 2022 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), (unknown), Lorena López‐Ferreras, (unknown), (unknown), (unknown), (unknown), (unknown), Benilde Jiménez, Lars Holmgren, Margareta Wilhelm, Jaime Millán, Luis del Peso, Lena Claesson‐Welsh, Margarita M. Marqués, María C. Marín	6
7	The E-cadherin/AmotL2 complex organizes actin filaments required for epithelial hexagonal packing and blastocyst hatching 2017 ·Scientific Reports ·(unknown), (unknown), (unknown), Sophie Petropoulos, Yuanyuan Zhang, Xiaofang Cao, John Patrick Mpindi, (unknown), Staffan Johansson, Årindam Majumdar, Fredrik Lanner, Lars Holmgren	23
8	Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ 2014 ·EJNMMI Research ·Erik Samén, Frank Leigh Lu, Jan Mulder, Jan-Olov Thorell, Peter Damberg, (unknown), Lars Holmgren, Helene Rundqvist, Sharon Stone‐Elander	4
9	A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors 2012 ·Angiogenesis ·Maddalena Arigoni, Giuseppina Barutello, Stefania Lanzardo, Dario Livio Longo, Silvio Aime, Claudia Curcio, Manuela Iezzi, Yujuan Zheng, Irmeli Barkefors, Lars Holmgren, Federica Cavallo	34
10	Regional Control of Tumor Growth 2010 ·Molecular Cancer Research ·A. Zaslavsky, Catherine Chen, (unknown), Kwan‐Hyuck Baek, Lars Holmgren, Sam S. Yoon, Judah Folkman, Sandra Ryeom	18
11	Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009 2010 ·Journal of Internal Medicine ·Marie Eriksson, Lars Holmgren, Urban Janlert, Jan‐Håkan Jansson, Dan Lundblad, Bernd Stegmayr, Stefan Söderberg, Mats Eliasson	125
12	Horizontal gene transfer: You are what you eat 2010 ·Biochemical and Biophysical Research Communications ·Lars Holmgren	26
13	Gender differences in trends of acute myocardial infarction events: The Northern Sweden MONICA study 1985 – 2004 2008 ·BMC Cardiovascular Disorders ·Dan Lundblad, Lars Holmgren, Jan‐Håkan Jansson, Ulf Näslund, Mats Eliasson	50
14	Angiomotin regulates endothelial cell migration during embryonic angiogenesis 2007 ·Genes & Development ·Karin Aase, (unknown), Lwaki Ebarasi, Lars Jakobsson, Årindam Majumdar, Chunling Yi, Olivier Birot, Yue Ming, Anders Kvanta, (unknown), Pontus Aspenström, Joseph L. Kissil, Lena Claesson‐Welsh, Akihiko Shimono, Lars Holmgren	122
15	A Cre‐loxP based system for studying horizontal gene transfer 2007 ·FEBS Letters ·Anna Bergsmedh, (unknown), Anna‐Lena Spetz, Lars Holmgren	5
16	Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer 2006 ·BMC Cancer ·Wen G. Jiang, Gareth M. Watkins, Anthony Douglas-Jones, Lars Holmgren, Robert E. Mansel	56
17	Angiomotin expression promotes hemangioendothelioma invasion 2004 ·Oncogene ·(unknown), Anders Bratt, Jack L. Arbiser, Lars Holmgren	39
18	Induction of HIV-1-Specific Immunity After Vaccination with Apoptotic HIV-1/Murine Leukemia Virus-Infected Cells 2002 ·The Journal of Immunology ·Anna‐Lena Spetz, Anna Smed‐Sörensen, Lilian Walther–Jallow, Britta Wahrén, Jan Andersson, Lars Holmgren, Jorma Hinkula	28
19	Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth 1994 ·Cold Spring Harbor Symposia on Quantitative Biology ·M. OʼReilly, Lars Holmgren, Yuen Shing, (unknown), Rosalind A. Rosenthal, Yiting Cao, Marsha A. Moses, W S Lane, E. Helene Sage, Judah Folkman	172
20	The Expression of PDGF α- and β-Receptors in Subpopulations of PDGF-Producing Cells Implicates Autocrine Stimulatory Loops in the Control of Proliferation in Cytotrophoblasts that Have Invaded the Maternal Endometrium 1992 ·Growth Factors ·Lars Holmgren, Lena Claesson‐Welsh, Carl‐Henrik Heldin, Rolf Ohlsson	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact